We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 814

Antitrust enforcement in the medical devices sector

  • Sidley Austin LLP
  • -
  • USA
  • -
  • March 25 2015

Enforcement agencies and courts in the United States have long dealt with high-profile antitrust cases in the pharmaceutical sector. However, until

Biosimilars in the US: still at the starting line?

  • DLA Piper LLP
  • -
  • USA
  • -
  • March 24 2015

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) in 2009 to create a framework for the introduction of biosimilar and

Joint FTC and DOJ workshop on healthcare competition highlights the importance of antitrust

  • Manatt Phelps & Phillips LLP
  • -
  • USA
  • -
  • March 23 2015

On February 24 and 25 in Washington, DC, the Federal Trade Commission (FTC) and the Department of Justice (DOJ) held a joint Antitrust Division

Outlook for 2015: antitrust litigation in the pharma industrymore than just Actavis progeny

  • Hogan Lovells
  • -
  • USA
  • -
  • March 19 2015

In 2014 there were a number of significant antitrust developments for the pharmaceutical industry. These involved not only pharmaceutical patent

Supreme Court addresses antitrust liability for state regulatory bodies

  • Dykema Gossett PLLC
  • -
  • USA
  • -
  • March 19 2015

The Supreme Court recently stripped some state regulatory agencies and boards of the ability to shield themselves from antitrust liability unless

No state action antitrust immunity for North Carolina Dental Board: implications for the health care sector

  • Epstein Becker Green
  • -
  • USA
  • -
  • March 17 2015

On February 25, 2015, the Supreme Court of the United States held that the North Carolina Dental Board ("Board") was not insulated from federal

Examining healthcare competition: a report from the FTCDOJ workshop

  • Squire Patton Boggs
  • -
  • USA
  • -
  • March 13 2015

The US Federal Trade Commission (FTC) and Department of Justice (DOJ) recently held the second of a series of workshops designed to enhance their

State health regulatory bodies have teeth pulled

  • Baker & Hostetler LLP
  • -
  • USA
  • -
  • March 12 2015

Old and new regulations established by state professional boards that are composed of "active market participants" such as physicians, dentists and

Supreme Court holds that state licensing board actions may not be protected by the state-action doctrine

  • Weil Gotshal & Manges LLP
  • -
  • USA
  • -
  • March 6 2015

The Supreme Court recently placed limits on the abilities of state regulatory agencies staffed by industry participants to regulate their industries

Supreme Court requires state supervision of professional boards to secure antitrust immunity

  • Jones Day
  • -
  • USA
  • -
  • March 6 2015

In an important decision, the U.S. Supreme Court has held that, where a state professional regulatory board is controlled by active market